10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
New single cell and spatial products set to deliver higher performance, improve ease of use and enable researchers to measure more biology
PLEASANTON, Calif., Feb. 5, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a series of new products and technology demonstrations that will be presented at the 2024 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Orlando, Florida.
Related news for (TXG)
- 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
- Addentax Group Corp. Enters Into US$1.3 Billion Term Sheet for Proposed Acquisition of Up to 12,000 Bitcoins
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/02/25 09:00 AM
- 24/7 Market News Snapshot 02 July, 2025 – Addentax Group Corp. Common Stock (NASDAQ:ATXG)
- Today’s Top Performers: MoBot’s Market Review 05/30/25 06:00 PM